LevitasBio

About:

LevitasBio is advancing science and human health by providing researchers with a new and powerful method of cellular analysis.

Website: http://levitasbio.com/

Top Investors: Decheng Capital, Pavilion Capital, Novalis LifeSciences

Description:

Levitas is redefining cellular analytics with its novel platform of magnetic levitation technology. Their disruptive technology overcomes the current technological limitations of cellular analysis by providing label-free, simple, and universal methods of analysis. The company's platform, the LeviCell enables studies and beneficial uses of previously inaccessible, high-value primary samples and sensitive cell types regardless of the starting cell number, viability, or sensitivity to processing.

Total Funding Amount:

$72.8M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2017-01-01

Founders:

Gozde Durmus, Lars Steinmetz, Utkan Demirci

Number of Employees:

51-100

Last Funding Date:

2024-03-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai